Aliya Z. Omer
About Aliya Z. Omer
Aliya Z. Omer serves as the Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma, a position she has held since 2020. She holds an MBA from INSEAD and a BS in Materials Science Engineering and Biomedical Engineering from Carnegie Mellon University.
Work at Kite Pharma
Aliya Z. Omer has been serving as the Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma since 2020. In this role, she is responsible for overseeing the strategic direction of the company's global portfolio and program initiatives. Kite Pharma is known for its focus on innovative cancer therapies, particularly in the field of cell therapy. Omer's leadership contributes to the advancement of Kite's mission to improve patient outcomes through cutting-edge treatments.
Previous Experience at Novartis
Before her tenure at Kite Pharma, Aliya Z. Omer worked at Novartis from 2008 to 2020. She held the position of Vice President for the Solid Tumors Franchise Sales. During her 12 years at Novartis, she played a significant role in driving sales strategies and enhancing the company's presence in the oncology market. Her experience in this capacity equipped her with valuable insights into the pharmaceutical industry and solid tumor treatments.
Background in Engineering and Business
Aliya Z. Omer has a strong educational background in both engineering and business. She earned her Bachelor of Science degree in Materials Science Engineering and Biomedical Engineering from Carnegie Mellon University. Additionally, she obtained her Master of Business Administration (MBA) from INSEAD. This combination of technical and business education has provided her with a unique perspective in her roles within the pharmaceutical industry.
Career at Johnson & Johnson
Aliya Z. Omer began her career at Johnson & Johnson, where she worked as a Staff Scientist from 2002 to 2007. In this role, she contributed to various scientific projects, gaining experience in research and development. Her time at Johnson & Johnson laid the foundation for her future roles in the pharmaceutical sector, allowing her to develop a solid understanding of scientific principles and their applications in healthcare.